0001140361-20-015434.txt : 20200706 0001140361-20-015434.hdr.sgml : 20200706 20200706171845 ACCESSION NUMBER: 0001140361-20-015434 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200623 FILED AS OF DATE: 20200706 DATE AS OF CHANGE: 20200706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: King Michael N. CENTRAL INDEX KEY: 0001816304 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37568 FILM NUMBER: 201014311 MAIL ADDRESS: STREET 1: 303A COLLEGE ROAD EAST CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDS Biotechnology Corp CENTRAL INDEX KEY: 0001472091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264231384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25B VREELAND ROAD CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: 800-208-3343 MAIL ADDRESS: STREET 1: 25B VREELAND ROAD CITY: FLORHAM PARK STATE: NJ ZIP: 07932 FORMER COMPANY: FORMER CONFORMED NAME: Edge Therapeutics, Inc. DATE OF NAME CHANGE: 20090911 3 1 form3.xml FORM 3 X0206 3 2020-06-23 0 0001472091 PDS Biotechnology Corp PDSB 0001816304 King Michael N. C/O PDS BIOTECHNOLOGY CORPORATION 25B VREELAND ROAD FLORHAM PARK NJ 07932 true Interim Chief Financial Office Employee Stock Option (Right to Buy) 6.87 2019-03-15 2024-12-15 Common Stock 52934 D Employee Stock Option (Right to Buy) 9.04 2019-03-14 2029-03-14 Common Stock 44871 D On December 15, 2014, the date of grant, the option was subject to the following vesting schedule: 16,227 options vested on the date of grant and on each monthly anniversary of the date of grant, 1/24 of the options vested. On March 15, 2019, in connection with the merger between the Issuer and private PDS Biotechnology Corporation, the option was accelerated and the shares underlying the option became fully vested and immediately exercisable. The option was fully vested and immediately exercisable on the date of grant. /s/ Michael N. King 2020-07-06